|
|
The estimation of patient's exposure dose during esophageal stent placement under X-ray fluoroscopy |
ZHANG Lin, YANG Shuhui, NIU Fei, MIN Nan, LI Zhen, LI Hailiang, SONG Gang, SUN Weihang, LIU Hanxiao, ZHU Jianguo |
School of Preventive Medicine Sciences (Institute of Radiation Medicine),Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250062 China |
|
|
Abstract Objective To estimate patient's exposure dose during esophageal stent placement under X-ray fluoroscopy through anthropomorphic phantom experiments.Methods Investigated 60 cases of esophageal stent implantation provincial tertiary hospitals and recorded intraoperative fluoroscopy time, tube voltage, tube current and other information. The anthropomorphic phantom experiments were divided into 3 groups according to the duration of fluoroscopy, cumulative dose and the size of the DAP, and a pyroelectric dosimeter was placed in predetermined holes within the anthropomorphic phantom to restore the surgical procedure in groups according to the experimental conditions. The patient's dose was estimated based on the results of the thermoluminescence dosimeter.Results In this study, under X-ray fluoroscopic esophageal stent placement, the effective doses for patients in the high, medium, and low dose groups were 10.773, 4.004 and 1.889 mSv, respectively. The highest values of absorbed dose from different tissues or organs in the three dose groups (high, medium and low) were in the red bone marrow, followed by muscle, esophagus and lung, with the lowest values in the testes.Conclusion Estimates of the effective dose to patients were proportional to the duration of fluoroscopy, cumulative dose, and size of DAP in the experimental conditions. The magnitude of the absorbed dose to the same tissue and organ increases with increasing fluoroscopy time in different dose groups. The amount of absorbed dose to different tissues and organs in the same dose group is closely related to the tissue weighting factor, the magnitude of the mass-energy absorption coefficient and whether the tissue or organ is irradiated by the main beam.
|
Received: 13 May 2020
|
|
|
|
|
[1] 吴光荣. DSA下食管支架置入术治疗食管恶性狭窄的临床分析[J]. 世界最新医学信息文摘,2015,15(7):54-55 [2] Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917 [3] Mangiavillano B, Pagano N, Arena M, et al. Role of stenting in gastrointestinal benign and malignant diseases[J]. World J Gastrointest Endosc, 2015, 7(5): 460-480 [4] 吴小勤, 张广云, 薛瑞, 等. X线透视下食管下段贲门癌支架置入术的临床分析[J]. 实用临床医药杂志,2013,17(11):141-142 [5] 赵素清, 杨海平, 毛宇. 内镜联合X线监视下支架植入治疗中晚期食管癌恶性梗阻的临床应用[J]. 中华胸部外科电子杂志,2018,5(3):168-172 [6] Ferreira F, Bastos P, Ribeiro A, et al. A comparative study between fluoroscopic and endoscopic guidance in palliative esophageal stent placement[J]. Dis Esophagus, 2012, 25(7): 608-613 [7] 文卫锋, 张建华, 孔小锋, 等. 胃镜联合数字减影血管造影引导支架植入术治疗重度狭窄食管癌36例分析[J]. 实用医学影像杂志,2015,16(5):369-371 [8] 常廷民, 李建生, 李秀敏. 内镜与X线下支架置入治疗食管贲门癌的疗效对比研究[J]. 现代预防医学,2013,40(7):1394-1396 [9] Chapman T, Tyrell H, Al-Hassani H, et al. PTU-055 A comparison of radiological and endoscopic oesophageal stent placement in malignancy[J]. Gut, 2014, 63(Suppl 1): A62. 2-A62 [10] 廖小勇, 文毅, 邱干, 等. 食管支架置入术在中晚期食管癌治疗中的应用进展[J]. 现代消化及介入诊疗,2019,24(5):550-553 [11] International Commission on Radiological Protection. ICRP Publication 103. The 2007 Recommendations of the International Commission on Radiological Protection[R]. Ann ICRP, 2007, 37(2-4): 65. [12] 李士俊. 电离辐射剂量学基础[M]. 苏州: 苏州大学出版社, 2008. [13] 吴在德, 吴肇汉. 外科学. 第七版[M]. 北京: 人民卫生出版社, 2010. [14] 张琳, 朱建国, 闵楠, 等. 3种常见介入诊疗中放射工作人员有效剂量的估算[J]. 中华放射医学与防护杂志,2011,31(4):391-394 [15] 张琳, 朱建国, 刘长才, 等. 成年受检者数字断层融合扫描有效剂量估算[J]. 中华放射医学与防护杂志,2018,38(6):451-455 [16] 朱建国, 王涛, 杨淑慧, 等. 经内镜逆行胰胆管造影术诊疗中患者受照剂量的模拟实验测量[J]. 中华放射医学与防护杂志,2020,40(1):55-58
|
|
|
|